Literature DB >> 19043224

Tanshinone IIA interacts with DNA by minor groove-binding.

Zhichao Zhang1, Jing Zhang, Liji Jin, Ting Song, Guiye Wu, Jin Gao.   

Abstract

Tanshen has long been widely used as a traditional Chinese medicine. Tanshinone IIA (Tan IIA) is the most abundant lipophilic constituent of Tanshen which has antitumor activity but the mechanism is poorly understood. Some preliminary reports hypothesized that it is a DNA intercalator and that the furano-o-quinone moiety could produce free radicals responsible for its cytotoxicity. Here the interaction of Tan IIA with DNA was explored in detail using fluorescence, viscosimetry, and molecular modeling. Tan IIA was found to bind with DNA in the minor groove rather than act as an intercalator. Furthermore, the results of immunofluorescence showed that Tan IIA does not produce free radicals in vivo to damage DNA. The former hypothesis was thus negated. The furan oxygen plays the key role in the antitumor ability of Tan IIA because it is involved in the groove-binding, but not in the production of free radicals. The molecular basis illustrated here could be responsible for all the findings in the structure-relationship studies of tanshinone cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19043224     DOI: 10.1248/bpb.31.2342

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.

Authors:  Joana Soares; Brian R Keppler; Xihong Wang; Kuo-Hsiung Lee; Michael B Jarstfer
Journal:  Bioorg Med Chem Lett       Date:  2011-10-08       Impact factor: 2.823

2.  Effect of phytochemical intervention on dibenzo[a,l]pyrene-induced DNA adduct formation.

Authors:  Gilandra K Russell; Ramesh C Gupta; Manicka V Vadhanam
Journal:  Mutat Res       Date:  2015-02-25       Impact factor: 2.433

3.  [Growth inhibition of tanshinones on SPC-A-1 cell line and their structure-activity relationship].

Authors:  Huayue Shi; Qing Zhang; Hui Li; Ting Chu; Hui Jin; Shengjun Mao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-01

Review 4.  Targeting Transcription Factors for Cancer Treatment.

Authors:  Mélanie Lambert; Samy Jambon; Sabine Depauw; Marie-Hélène David-Cordonnier
Journal:  Molecules       Date:  2018-06-19       Impact factor: 4.411

5.  Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.

Authors:  Lian Zheng; Zhen-Jie Guan; Wen-Ting Pan; Tian-Feng Du; Yu-Jia Zhai; Jia Guo
Journal:  Oncol Res       Date:  2017-05-21       Impact factor: 5.574

6.  A 2-oxoglutarate-dependent dioxygenase converts dihydrofuran to furan in Salvia diterpenoids.

Authors:  Jiao-Jiao Song; Xin Fang; Chen-Yi Li; Yan Jiang; Jian-Xu Li; Sheng Wu; Juan Guo; Yan Liu; Hang Fan; Yan-Bo Huang; Yu-Kun Wei; Yu Kong; Qing Zhao; Jing-Jing Xu; Yong-Hong Hu; Xiao-Ya Chen; Lei Yang
Journal:  Plant Physiol       Date:  2022-03-04       Impact factor: 8.340

Review 7.  Molecular Mechanism of Tanshinone against Prostate Cancer.

Authors:  Wei Li; Tao Huang; Shenghan Xu; Bangwei Che; Ying Yu; Wenjun Zhang; Kaifa Tang
Journal:  Molecules       Date:  2022-08-30       Impact factor: 4.927

Review 8.  Tanshinones: sources, pharmacokinetics and anti-cancer activities.

Authors:  Yong Zhang; Peixin Jiang; Min Ye; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

9.  Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway.

Authors:  I-Yun Lee; Yin-Yin Lin; Yao-Hsu Yang; Yu-Shin Lin; Chun-Liang Lin; Wei-Yu Lin; Yu-Ching Cheng; Li-Hsin Shu; Ching-Yuan Wu
Journal:  BMC Pharmacol Toxicol       Date:  2018-01-31       Impact factor: 2.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.